Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PTO Lobbies Against Damages Award Provision In Patent Reform Bill

This article was originally published in The Gray Sheet

Executive Summary

The Bush administration is actively lobbying the Senate Judiciary Committee to change a provision in pending patent reform legislation dealing with infringement damage awards

You may also be interested in...



Sens. Leahy, Kyl To Continue Push For Patent Reform In Next Congress

Encouraged by Nov. 4 election results that increased the number of Democrats in the Senate, Senate Judiciary Committee Chairman Patrick Leahy, D-Vt., will reintroduce his controversial patent reform bill in 2009, committee staff said

Sens. Leahy, Kyl To Continue Push For Patent Reform In Next Congress

Encouraged by Nov. 4 election results that increased the number of Democrats in the Senate, Senate Judiciary Committee Chairman Patrick Leahy, D-Vt., will reintroduce his controversial patent reform bill in 2009, committee staff said

Patent Bill Damages Provision Still Up For Debate – Senate Committee Report

A Senate Judiciary Committee 1report on a pending patent reform bill suggests a controversial provision on calculating infringement damages is still ripe for revision, but bill authors will not stray too far from their original intent

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025765

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel